Elephas Biosciences announced recently that Neuberg Diagnostics will become its commercial partner in India.

According to a release, Neuberg will process tumor biopsy samples on the elive platform at its flagship laboratory in Ahmedabad.

“We’re excited to partner with Neuberg Diagnostics, a recognized leader in oncology diagnostics with an established presence across India,” Elephas Founder and CEO Maneesh Arora said in a statement. “Pairing their molecular diagnostics expertise with the elive platform lays the groundwork to bring functional immunotherapy response assessment to oncology care in India.”

The two companies look to launch a clinical test in India by the end of the year.